Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Journal of Hepatology|June 28, 2011
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosisChristophe Corpechot, Farid Gaouar, Yves Chrétien, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2009
Significance of antibodies to soluble liver antigen/liver pancreas: a large French studyViolaine Eyraud, Olivier Chazouilleres, Eric Ballot, et al.
Gastroenterology|February 3, 2005
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosisChristophe Corpechot, Fabrice Carrat, Abbas Bahr, et al.
Journal of Medical Virology|January 19, 2024
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word settingChristophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, et al.
The American Journal of Pathology|February 13, 2002
Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosisChristophe Corpechot, Veronique Barbu, Dominique Wendum, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2023
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndromePierre-Antoine Soret, Sara Lemoinne, Maxime Mallet, et al.
Revista Espanola De Enfermedades Digestivas|November 20, 2018
Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variantsMinh-Tuan Huynh, Jean-Louis Delaunay, Laure Muller, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosisChristophe Corpechot, Fabrice Carrat, Armelle Poujol-Robert, et al.
European Radiology|August 31, 2018
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitisLaetitia Nguyen, Nora Cazzagon, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|May 1, 2002
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosisChristophe Corpechot, Veronique Barbu, Dominique Wendum, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Journal of Hepatology|June 28, 2011
Smoking as an independent risk factor of liver fibrosis in primary biliary cirrhosisChristophe Corpechot, Farid Gaouar, Yves Chrétien, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 24, 2009
Significance of antibodies to soluble liver antigen/liver pancreas: a large French studyViolaine Eyraud, Olivier Chazouilleres, Eric Ballot, et al.
Gastroenterology|February 3, 2005
The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosisChristophe Corpechot, Fabrice Carrat, Abbas Bahr, et al.
Journal of Medical Virology|January 19, 2024
Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word settingChristophe Corpechot, Marie Verdoux, Marie Frank-Soltysiak, et al.
The American Journal of Pathology|February 13, 2002
Hepatocyte growth factor and c-Met inhibition by hepatic cell hypoxia: a potential mechanism for liver regeneration failure in experimental cirrhosisChristophe Corpechot, Veronique Barbu, Dominique Wendum, et al.
Alimentary Pharmacology & Therapeutics|October 11, 2023
Obeticholic acid as a second-line treatment for low phospholipid-associated cholelithiasis syndromePierre-Antoine Soret, Sara Lemoinne, Maxime Mallet, et al.
Revista Espanola De Enfermedades Digestivas|November 20, 2018
Expanding the mutational spectrum of the ABCB4 gene in inherited adult cholestatic liver disorders with four novel pathogenic variantsMinh-Tuan Huynh, Jean-Louis Delaunay, Laure Muller, et al.
Hepatology (Baltimore, Md.)|January 25, 2012
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosisChristophe Corpechot, Fabrice Carrat, Armelle Poujol-Robert, et al.
European Radiology|August 31, 2018
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitisLaetitia Nguyen, Nora Cazzagon, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|May 1, 2002
Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosisChristophe Corpechot, Veronique Barbu, Dominique Wendum, et al.
Pageof 12